已收盘 09-05 16:00:00 美东时间
+0.480
+2.42%
Morgan Stanley analyst Erin Wilson maintains Rapid7 (NASDAQ:RPD) with a Equal-Weight and lowers the price target from $28 to $22.
09-02 21:24
集团新闻 CNAS评审专家莅临北京澳合药物研究院 北京澳合药物研究院通过CNAS认证 < 近日,四环医药集团全资子公司北京澳合药物研究院成功通过中国合格评...
08-28 12:06
Rapid7, a leader in threat detection and exposure management, has been named a Leader in the IDC MarketScape: Worldwide Exposure Management 2025 Vendor Assessment. The company's Command Platform, an AI-powered security operations solution, was recognized for its ability to unify exposure management and threat detection. Rapid7 delivers its exposure management capabilities through Exposure Command, which offers unified visibility, real-world risk ...
08-27 13:00
Rapid7 launches Vector Command Advanced, integrating expanded continuous red-teaming with attack surface management to unify internal penetration testing and compliance validation. The service helps organizations meet standards like PCI, ISO 27001, and NIST, offering expert-led validation across firewalls, internal control testing, and real-world attack simulations. Features include Surface Command integration, persistent reconnaissance, attack p...
08-19 13:00
Citigroup analyst Fatima Boolani maintains Rapid7 (NASDAQ:RPD) with a Buy and lowers the price target from $35 to $30.
08-18 23:37
Rapid7的2025《初始访问经纪商报告》揭示了地下市场中网络犯罪分子如何以极低价格(通常低于1000美元)出售企业网络访问权限,往往包含管理员特权甚至多类型访问。报告指出,"初始"访问并不意味着仅限于初步入侵,而是可能对企业造成深度妥协。此外,Rapid7呼吁通过多因素认证、威胁驱动的检测与响应以及定期红队演习来加强防御,同时强调威胁检测与暴露管理需紧密整合以有效应对网络攻击。
08-12 13:00
今日重点评级关注:Northland Capital Markets:维持Groupon"跑赢大市"评级,目标价从39美元升至44美元;道明证券:维持Nutrien"买入"评级,目标价从70美元升至72美元
08-12 09:15
Rapid7 announced its participation in two upcoming conferences: the Canaccord Genuity 45th Annual Growth Conference in Boston, MA, on August 12 at 9:30 a.m. ET, and the Piper Sandler Growth Frontiers Conference in Nashville, TN, on September 10 at 1:30 p.m. CT. Both presentations will be webcast live and available for replay under the "Events and Presentations" section on investors.rapid7.com. Rapid7 aims to enhance cybersecurity by simplifyin...
08-11 20:01
今日重点评级关注:RBC Capital:维持Edgewise Therapeutics"跑赢大市"评级,目标价从48美元升至49美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从6美元升至7美元
08-11 09:43
Rapid7 (NASDAQ:RPD) underwent analysis by 18 analysts in the last quarter, reve...
08-09 03:02